Answers are grounded in this paper and cite their sources.
To investigate trends in FDA regulatory approvals and development decisions for neurology and related therapies, analyzing Center for Drug Evaluation and Research (CDER) data.
No takes yet. Share an insight, caveat, or question.
Andreas Lysandropoulos (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: